As filed with the Securities and Exchange Commission on December 21, 2020
Registration No. 333-188368
Registration No. 333-106007
Registration No. 333-104828
Registration No. 333-96541
Registration No. 333-87736
Registration No. 333-67370
Registration No. 333-59380
Registration No. 333-39238
Registration No. 333-94367
Registration No. 333-86611
Registration No. 333-40681
Registration No. 333-38055
Registration No. 333-26979
Registration No. 333-00391
Registration No. 033-59009
Registration No. 033-57583
Registration No. 33-52252
Registration No. 33-40295
Registration No. 33-40294
Registration No. 33-32875
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-188368
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-106007
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-104828
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-96541
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-87736
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-8 REGISTRATION STATEMENT NO. 333-67370
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-8 REGISTRATION STATEMENT NO. 333-59380
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-39238
POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-8 REGISTRATION STATEMENT NO. 333-93467
POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-8 REGISTRATION STATEMENT NO. 333-86611
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-40681
POST-EFFECTIVE AMENDMENT NO. I TO FORM S-8 REGISTRATION STATEMENT NO. 333-38055
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-26979
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-00391
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 033-59009
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 033-57583
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 33-52252
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 33-40295
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 33-40294
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 33-32875
UNDER THE SECURITIES ACT OF 1933
JOHNSON & JOHNSON
(Exact name of registrant as specified in its charter)
New Jersey | 22-1024240 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
(732) 524-0400
(Address of Principal Executive Offices)
JOHNSON & JOHNSON RETIREMENT SAVINGS PLAN
JOHNSON & JOHNSON SAVINGS PLAN FOR UNION REPRESENTED EMPLOYEES
JOHNSON & JOHNSON SAVINGS PLAN
JOHNSON & JOHNSON 2000 STOCK OPTION PLAN
SCIOS INC. 1992 EQUITY INCENTIVE PLAN
SCIOS INC. 1996 NON-OFFICER STOCK OPTION PLAN
JOHNSON & JOHNSON SAVINGS PLAN
ALZA CORPORATION TAX DEFERRAL INVESTMENT PLAN
SELFCARE, INC. EMPLOYEE STOCK PURCHASE PLAN
SELFCARE, INC. 1992 STOCK PLAN
SELFCARE, INC. 1994 INCENTIVE AND NONQUALIFIED STOCK OPTION PLAN
SELFCARE, INC. AMENDED AND RESTATED 1996 STOCK OPTION AND GRANT PLAN
STOCK OPTION GRANTS TO KEITH MAY, JEROME MCALEER AND DAVID SCOTT
INVERNESS MEDICAL TECHNOLOGY, INC. AMENDED AND RESTATED 2000 STOCK OPTION AND
GRANT PLAN INTEG INCORPORATED (FORMERLY INOMET, INC.) 1990 INCENTIVE AND STOCK
OPTION PLAN INTEG INCORPORATED (FORMERLY INOMET, INC.) 1991 INCENTIVE AND STOCK
OPTION PLAN INTEG INCORPORATED 1994 LONG-TERM INCENTIVE AND STOCK OPTION PLAN
INTEG INCORPORATED 1996 DIRECTORS’ STOCK OPTION PLAN
ALZA CORPORATION AMENDED AND RESTATED STOCK PLAN
ALZA CORPORATION AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN
ALZA CORPORATION SUPPLEMENTAL EMPLOYEE STOCK PURCHASE PLAN
ALZA CORPORATION NONSTATUTORY STOCK OPTION PLAN
SEQUUS PHARMACEUTICALS, INC. 1987 EMPLOYEE STOCK OPTION PLAN
SEQUUS PHARMACEUTICALS, INC. 1987 CONSULTANT STOCK OPTION PLAN
SEQUUS PHARMACEUTICALS, INC. 1990 DIRECTOR STOCK PLAN
SEQUUS PHARMACEUTICALS, INC. EQUITY INCENTIVE PLAN
INNOVASIVE DEVICES, INC. 1992 STOCK OPTION PLAN
INNOVASIVE DEVICES, INC. 1996 NON-EMPLOYEE DIRECTOR STOCK PLAN
INNOVASIVE DEVICES, INC. 1996 OMNIBUS STOCK PLAN
CENTOCOR, INC. CONSULTANT NON-QUALIFIED STOCK OPTION AGREEMENTS
CENTOCOR, INC. 1983 INCENTIVE STOCK OPTION PLAN
CENTOCOR, INC. 1987 NON-QUALIFIED STOCK OPTION PLAN
CENTOCOR, INC. 1989 NON-EMPLOYEE DIRECTORS’ NON-QUALIFIED STOCK OPTION PLAN
GYNECARE, INC., 1994 STOCK PLAN
GYNECARE, INC. 1995 DIRECTOR OPTION PLAN
JOHNSON & JOHNSON/BIOSENSE (ISRAEL) LTD. 1995 STOCK OPTION PLAN
JOHNSON &JOHNSON/BIOSENSE, INC. 1996 STOCK OPTION PLAN
JOHNSON & JOHNSON STOCK OPTION PLAN FOR NON-EMPLOYEE DIRECTORS
THE CORDIS CORPORATION NON-QUALIFIED STOCK OPTION PLAN
THE CORDIS CORPORATION DIRECTOR NON-QUALIFIED STOCK OPTION PLAN
THE WEBSTER LABORATORIES, INC. 1992 STOCK PLAN
JOHNSON & JOHNSON 1995 STOCK OPTION PLAN
JOHNSON & JOHNSON 1991 STOCK OPTION PLAN
MITEK SURGICAL PRODUCTS, INC. 1988 STOCK OPTION PLAN
MITEK SURGICAL PRODUCTS, INC. NON-EMPLOYEE DIRECTOR STOCK OPTION PLAN
JOHNSON & JOHNSON 1991 STOCK OPTION PLAN
(Full title of the plan)
Matthew Orlando
Johnson & Johnson
Corporate Secretary
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
(Name and address of agent for service)
Telephone: (732) 524-0400
(Telephone number, including area code, of agent for service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act of 1934.
Large accelerated filer | ☒ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☐ (Do not check if a smaller reporting company) | Smaller reporting company | ☐ | |||
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
DEREGISTRATION OF SECURITIES
Johnson & Johnson (the “Registrant”) is filing these Post-Effective Amendments (“Amendments”) to those certain Registration Statements on Form S-8 (collectively, the “Registration Statements”) filed by Johnson & Johnson, a New Jersey corporation (“Johnson & Johnson”), as follows (note that the share numbers listed below do not take into account any corporate actions, such as stock splits, taken in the interim):
1. | Registration Statement on Form S-8 (File No. 333-188368) for the registration of 20,000,000 shares of common stock of the Registrant, par value $1.00 (“shares”), issuable under the Johnson & Johnson Retirement Savings Plan, the Johnson & Johnson Savings Plan for Union Represented Employees and the Johnson & Johnson Savings Plan. |
2. | Registration Statement on Form S-8 (File No. 333-106007) for the registration of 58,196,152 shares issuable under the Johnson & Johnson 2000 Stock Option Plan. |
3. | Registration Statement on Form S-8 (File No. 333-104828) for the registration of 7,010,000 shares issuable upon the exercise of stock options granted under the Scios Inc. 1992 Equity Incentive Plan and the Scios Inc. 1996 Non-Officer Stock Option Plan. |
4. | Registration Statement on Form S-8 (File No. 333-96541) for the registration of 50,000,000 shares issuable pursuant to the Johnson & Johnson Savings Plan. |
5. | Registration Statement on Form S-8 (File No. 333-87736) for the registration of 90,000 shares issuable pursuant to the ALZA Corporation Tax Deferral Investment Plan. |
6. | Post-Effective Amendment No. 1 on Form S-8 (File No 333-67370) for the registration of 2,758,151 shares issuable upon the exercise of stock options granted under the Selfcare, Inc. Employee Stock Purchase Plan, the Selfcare, Inc. 1992 Stock Plan, the Selfcare, Inc. 1994 Incentive and Nonqualified Stock Option Plan, the Selfcare, Inc. Amended and Restated 1996 Stock Option and Grant Plan, the Stock Option Grants to Keith May, Jerome McAleer and David Scott, the Inverness Medical Technology, Inc. Amended and Restated 2000 Stock Option and Grant Plan, the Integ Incorporated (formerly Inomet, Inc.) 1990 Incentive and Stock Option Plan, the Integ Incorporated (formerly Inomet, Inc.) 1991 Incentive and Stock Option Plan, the Integ Incorporated 1994 Long-Term Incentive and Stock Option Plan and the Integ Incorporated 1996 Directors’ Stock Option Plan. |
7. | Post-Effective Amendment No. 1 on Form S-8 (File No. 333-59380) for the registration of 17,859,435 shares issuable upon the exercise of stock options granted under the ALZA Corporation Amended and Restated Stock Plan, the ALZA Corporation Amended and Restated Employee Stock Purchase Plan, the ALZA Corporation Supplemental Employee Stock Purchase Plan, the ALZA Corporation Nonstatutory Stock Option Plan, the SEQUUS Pharmaceuticals, Inc. 1987 Employee Stock Option Plan, the SEQUUS Pharmaceuticals, Inc. 1987 Consultant Stock Option Plan, the SEQUUS Pharmaceuticals, Inc. 1990 Director Stock Plan and the SEQUUS Pharmaceuticals, Inc. Equity Incentive Plan. |
8. | Registration Statement on Form S-8 (File No. 333-39238) for the registration of 75,000,000 shares issuable under the Johnson & Johnson 2000 Stock Option Plan. |
9. | Post-Effective Amendment No. 1 on Form S-8 (File No. 333-94367) for the registration of 183,617 shares issuable upon the exercise of stock options granted under the Innovasive Devices, Inc., 1992 Stock Option Plan, Innovasive Devices, Inc. 1996 Non-Employee Director Stock Plan and Innovasive Devices, Inc. 1996 Omnibus Stock Plan. |
10. | Post-Effective Amendment No. 1 and Post-Effective Amendment No. 2 on Form S-8 (File No. 333-86611) for the registration of a total of 3,458,789 shares issuable upon the exercise of stock option granted under the Centocor, Inc. Consultant Non-Qualified Stock Option Agreements, the Centocor, Inc. 1983 Incentive Stock Option Plan, the Centocor, Inc. 1987 Non-Qualified Plan and the Centocor, Inc. 1989 Non-Employee Directors’ Non-Qualified Stock Option Plan. |
11. | Registration Statement on Form S-8 (File No. 333-40681) for the registration of 130,195 shares issuable under the Gynecare, Inc. 1994 Stock Plan and the Gynecare, Inc. 1995 Director Option Plan. |
12. | Registration Statement on Form S-8 (File No. 333-38055) for the registration of 819,239 shares issuable under the Johnson & Johnson/Biosense (Israel) Ltd. 1995 Stock Option Plan and the Johnson & Johnson/Biosense, Inc. 1996 Stock Option Plan. |
13. | Registration Statement on Form S-8 (File No. 333-26979) for the registration of 150,000 shares issuable under the Johnson & Johnson Stock Option Plan for Non-Employee Directors. |
14. | Post-Effective Amendment No. l on Form S-8 (File No. 333-00391) relating to the sale of up to 1,161,132 shares issuable upon the exercise of stock options granted under the Cordis Corporation Non-Qualified Stock Option Plan and The Webster Laboratories, Inc. 1992 Stock Option Plan. |
15. | Registration Statement on Form S-8 (File No. 033-59009) for the registration of 28,000,000 shares for the Johnson & Johnson 1995 Stock Option Plan. |
16. | Registration Statement on Form S-8 (File No. 033-57583) for the registration of 267,000 shares issuable upon the exercise stock options granted under the Mitek Surgical Products, Inc. 1988 Stock Option Plan and the Mitek Surgical Products, Inc. Non-Employee Director Stock Option Plan. |
17. | Registration Statement on Form S-8 (File No. 33-52252) for the registration of 200,000 shares issuable pursuant to the Johnson & Johnson Savings Plan for Union Represented Employees. |
18. | Registration Statement on Form S-8 (File No. 33-40295) for the registration of 13,000,000 shares issuable pursuant to the Johnson & Johnson 1991 Stock Option Plan. |
19. | Registration Statement on Form S-8 (File No. 33-40294) for the registration of 2,500,000 shares issuable pursuant to the Johnson & Johnson Savings Plan. |
20. | Registration Statement on Form S-8 (File No. 33-32875) for the registration of 384,937 shares issuable pursuant to the Johnson & Johnson Retirement Savings Plan. |
The offerings contemplated by the Registration Statements have been terminated. In accordance with the undertaking contained in the Registration Statements (pursuant to Item 512(a)(3) of Regulation S-K), Johnson & Johnson hereby removes from registration any securities that were registered but unsold under the Registration Statements. Accordingly, these Amendments are being filed to deregister any securities covered by the above referenced plans which remain unissued as of the date of this filing.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment to the Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New Brunswick, State of New Jersey on this 21st day of December, 2020.
Johnson & Johnson | ||
By: | /s/ A. Gorsky | |
A. Gorsky | ||
A. Gorsky, Chairman, Board of Directors and Chief Executive Officer |
Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment to the Registration Statements on Form S-8 has been signed by the following persons in their respective capacities and on the respective dates indicated opposite their names.
Signature |
Title |
Date | ||
/s/ A. Gorsky A. Gorsky |
Chairman, Board of Directors Chief Executive Officer (Principal Executive Officer) |
December 21, 2020 | ||
/s/ J. J. Wolk J. J. Wolk |
Executive Vice President, Chief Financial Officer (Principal Financial Officer) |
December 21, 2020 | ||
/s/ R. J. Decker Jr. R. J. Decker Jr. |
Controller (Principal Accounting Officer) |
December 21, 2020 | ||
/s/ M. C. Beckerle M. C. Beckerle |
Director | December 21, 2020 | ||
/s/ D. S. Davis D. S. Davis |
Director | December 21, 2020 | ||
/s/ I. E. L. Davis I. E. L. Davis |
Director | December 21, 2020 | ||
/s/ J. A. Doudna J. A. Doudna |
Director | December 21, 2020 | ||
/s/ M. A. Hewson M. A. Hewson |
Director | December 21, 2020 | ||
/s/ H. Joly H. Joly |
Director | December 21, 2020 | ||
/s/ M. B. McClellan |
Director | December 21, 2020 | ||
M. B. McClellan |
Signature |
Title |
Date | ||
/s/ A. M. Mulcahy |
Director | December 21, 2020 | ||
A. M. Mulcahy | ||||
/s/ C. Prince |
Director | December 21, 2020 | ||
C. Prince | ||||
/s/ A. E. Washington |
Director | December 21, 2020 | ||
A. E. Washington | ||||
/s/ M. A. Weinberger |
Director | December 21, 2020 | ||
M. A. Weinberger | ||||
/s/ N. West |
Director | December 21, 2020 | ||
N. West | ||||
/s/ R. A. Williams |
Director | December 21, 2020 | ||
R. A. Williams |